Summary: New research indicates that obstructive sleep apnea (OSA) is linked to early cognitive decline, reduced executive function, and diminished impulse control in middle-aged men—even when those men do not have obesity or other common co-morbid conditions.
Source: Frontiers
Obstructive sleep apnea (OSA) is a common and potentially serious sleep disorder. During sleep, the throat muscles relax and partially or fully block airflow to the lungs, causing repeated breathing interruptions.
Typical symptoms of OSA include restless nights, loud snoring, excessive daytime sleepiness, and persistent morning headaches—symptoms that can be deeply disruptive for patients and their partners.
OSA is widely underdiagnosed. Estimates suggest it may affect 15–30% of men and 10–15% of women, amounting to roughly one billion adults worldwide, with as many as 80% unaware they have the condition. Key risk factors include middle or older age, obesity, smoking, chronic nasal obstruction, high blood pressure, and male sex.
Researchers from the UK, Germany, and Australia have now reported evidence that, in middle-aged men, OSA alone can be associated with early cognitive decline—even in otherwise healthy, non-obese individuals without co-morbidities. These results were published in Frontiers in Sleep.
“We observed poorer executive functioning, impaired visuospatial memory, and deficits in vigilance, sustained attention, psychomotor speed, and impulse control in men with OSA,” said Dr Ivana Rosenzweig, head of the Sleep and Brain Plasticity Centre at King’s College London and lead author of the study. “Many of these problems had previously been attributed to co-morbid conditions rather than to OSA itself.”
The team also reports, for the first time in this population, notable impairments in social cognition—difficulties recognizing emotions and social cues—among men with OSA.
Study of a rare, otherwise healthy cohort
The research focused on 27 men aged 35 to 70 who had newly diagnosed mild to severe OSA but no additional medical co-morbidities. Such a cohort is uncommon because most people with OSA also have conditions like cardiovascular disease, diabetes, chronic inflammation, or depression. Participants were non-smokers, not alcohol dependent, and had body mass indexes (BMI) below 30.
As a comparison group, the investigators recruited seven men matched for age, BMI, and education who did not have OSA. The OSA diagnosis was confirmed using home-based WatchPAT respiratory monitoring and in-lab video-polysomnography at King’s College sleep center. The polysomnography recorded brain activity with EEG and tracked blood oxygen levels, heart rate, breathing, and eye and limb movements during sleep.
Cognitive performance was evaluated using the Cambridge Neuropsychological Test Automated Battery (CANTAB), a standardized set of computerized tests that measure memory, attention, executive function, and related domains.
Signs of premature cognitive decline
Compared with matched controls, men with severe OSA showed significantly poorer vigilance, reduced executive functioning, lower short-term visual recognition memory, and impaired social and emotion recognition. Men with mild OSA tended to perform between the control group and the severe OSA group—worse than controls but better than those with severe disease.
The most pronounced deficits appeared on tasks that required simultaneous visual matching and non-verbal short-term recognition memory, tests of executive function and attentional set shifting, sustained attention and psychomotor speed, and measures of social cognition and emotion recognition.
Based on these findings, the authors conclude that OSA itself can be sufficient to produce measurable cognitive deficits in middle age—deficits that earlier studies had often attributed to accompanying medical conditions such as hypertension, cardiovascular disease, metabolic disorders, or type 2 diabetes.
Potential mechanisms remain uncertain
The study discusses several plausible biological mechanisms linking OSA to cognitive decline. These include intermittent hypoxia (repeated drops in blood oxygen), elevated carbon dioxide levels, changes in cerebral blood flow, sleep fragmentation, and neuroinflammation. Together, these processes may trigger structural and functional changes across multiple brain regions, producing the cognitive and emotional impairments observed.
“The interplay among intermittent hypoxia, sleep disruption, vascular changes, and inflammation is complex and not yet fully understood,” said Rosenzweig. “However, our data suggest that OSA-driven processes can lead to early cognitive changes even in the absence of other medical conditions.”
Whether co-existing medical conditions add to or amplify the cognitive impact of OSA remains to be clarified. The authors describe this work as a proof of concept and propose future studies to determine whether co-morbidities exert additive or synergistic effects and whether brain circuitry differs between OSA patients with and without co-morbid conditions.
About this cognition research news
Author: Mischa Dijkstra
Source: Frontiers
Contact: Mischa Dijkstra – Frontiers
Image: The image is in the public domain
Original Research: Open access. “Distinct cognitive changes in male patients with obstructive sleep apnea without co-morbidities” by Ivana Rosenzweig et al., Frontiers in Sleep
Abstract
Distinct cognitive changes in male patients with obstructive sleep apnea without co-morbidities
Introduction: Obstructive sleep apnea (OSA) is a chronic, multisystem disorder of breathing during sleep that often produces a consistent pattern of cognitive difficulties. Some researchers have argued that cognitive problems in middle-aged patients may primarily stem from cardiovascular and metabolic co-morbidities, rather than from OSA-specific processes such as intermittent nocturnal hypoxaemia, oxidative stress, neuroinflammation, and sleep fragmentation.
Methods: To isolate the cognitive effects of OSA itself, this study evaluated 27 middle-aged men with untreated OSA and no concomitant co-morbidities, compared with seven matched controls (control AHI mean ± S.D.: 1.9 ± 1.4 events/h; mean age 34.0 ± 9.3 years; mean BMI 23.8 ± 2.3 kg/m2). Among the patients, 16 had mild OSA (AHI mean ± S.D.: 11.7 ± 4.0 events/h; mean age 42.6 ± 8.2 years; mean BMI 26.7 ± 4.1 kg/m2) and 11 had severe OSA (AHI 41.8 ± 20.7 events/h; mean age 46.9 ± 10.9 years; mean BMI 28.0 ± 3.2 kg/m2).
Results: In this cohort, the researchers found poorer executive functioning and visuospatial memory, plus deficits in vigilance, sustained attention, psychomotor speed, impulse control, and, notably, social cognition.
Conclusion: These results indicate that OSA-driven physiological processes may be sufficient to produce distinct cognitive changes as early as middle age, even in otherwise healthy individuals.